DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Ellis MJ, Suman VJ, Hoog J et al.
Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype-ACOSOG Z1031.
J Clin Oncol 2011;
29: 2342-2349
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.